Transplantation, AutologousHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyStem CellsCyclophosphamideTreatment OutcomeStem Cell TransplantationAntineoplastic AgentsTransplantation, HomologousChemotherapy, AdjuvantSalvage TherapyLymphoma, Non-HodgkinHematopoietic Stem CellsTransplantationHematologic NeoplasmsGraft vs Host DiseaseEmbryonic Stem CellsTransplantation ConditioningAdult Stem CellsImmunocompromised HostCytomegalovirus InfectionsDose-Response Relationship, DrugTissue DonorsBone Marrow TransplantationPluripotent Stem CellsTime FactorsOpportunistic InfectionsGraft SurvivalStem Cell NicheMycosesKidney TransplantationImmunosuppressive AgentsHematopoietic Stem Cell MobilizationHistocompatibility TestingAspergillosisSurvival AnalysisNeural Stem CellsSurvival RateInduced Pluripotent Stem CellsRetrospective StudiesMesenchymal Stem Cell TransplantationCell DifferentiationRecurrenceRoseolovirus InfectionsTransplantsHistocompatibilityDisease-Free SurvivalMultipotent Stem CellsCytomegalovirusNeoplasmsMultiple MyelomaPrognosisHematologic DiseasesStem Cell FactorFollow-Up StudiesWhole-Body IrradiationMesenchymal Stromal CellsCisplatinDrug Administration ScheduleLeukemiaFatal OutcomeBusulfanAntifungal AgentsDoxorubicinGraft RejectionAntiviral AgentsNeutropeniaProspective StudiesAntigens, CD34Transplantation ChimeraMelphalanGranulocyte Colony-Stimulating FactorCells, CulturedHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBreast NeoplasmsRisk FactorsCord Blood Stem Cell TransplantationCell LineageGanciclovirLeukemia, Myeloid, AcuteHerpesvirus 6, HumanAcute DiseaseHodgkin DiseaseEtoposideFlow CytometryBK VirusCyclosporineCell ProliferationZygomycosisStem Cell ResearchImmunosuppressionAnemia, AplasticStomatitisPolyomavirus InfectionsBone Marrow CellsPlant StemsLeukemia, Myelogenous, Chronic, BCR-ABL Positive